[an error occurred while processing this directive]
护理研究

维持性血液透析患者早期再入院影响因素的Meta分析

  • 梁琪 ,
  • 王志虎 ,
  • 王冰洁 ,
  • 刘洋 ,
  • 张春梅
展开
  • 301617 天津,1天津中医药大学护理学院

收稿日期: 2023-09-04

  修回日期: 2023-10-09

  网络出版日期: 2024-03-12

基金资助

天津市研究生科研创新项目(2022SKY239);天津中医药大学研究生科研创新项目(YJSKC-20221033)

Risk factors for early readmission of maintenance hemodialysis patients: a meta-analysis

  • LIANG Qi ,
  • WANG Zhi-Hu ,
  • WANG Bing-Jie ,
  • LIU Yang ,
  • ZHANG Chun-Mei
Expand
  • School of Nursing, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China

Received date: 2023-09-04

  Revised date: 2023-10-09

  Online published: 2024-03-12

摘要

目的 系统评价维持性血液透析患者再入院的影响因素,为早期识别并提供针对性干预提供参考。 方法 计算机检索PubMed、Embase、Web of Science、Cochrane Library、中国知网、万方数据库、维普数据库和中国生物医学文献数据库中关于维持性血液透析患者再入院的影响因素相关研究,检索时间为建库至2023年2月,采用RevMan 5.3软件进行Meta分析。 结果 共纳入13篇文献,774 826例患者。Meta分析结果显示:女性(OR=1.08,95% CI:1.05~1.11,P<0.001)、吸烟(OR=1.56,95% CI:1.09~2.23,P=0.010)、饮酒(OR=1.24,95% CI:1.04~1.48,=0.020)、药物误用(OR=1.08,95% CI:1.05~1.11,P<0.001)、脑血管疾病(OR=1.17,95% CI:1.08~1.26,P<0.001)、冠状动脉疾病(OR=1.27,95% CI:1.08~1.49,P<0.001)、心力衰竭(OR=1.2895% CI:1.19~1.37,P<0.001)、糖尿病(OR=1.13,95% CI:1.06~1.20,P<0.001)、慢性阻塞性肺疾病(OR=1.20,95% CI:1.12~1.28,P<0.001)、血红蛋白(MD=-9.29,95% CI:-14.06~-4.53,P<0.001)、白蛋白(MD=-3.51,95% CI:-4.44~-2.58,P<0.001)、中心静脉导管(OR=1.25,95% CI:1.15~1.37,P<0.001)为维持性血液透析患者早期再入院的危险因素。 结论 临床医护人员可依据相关危险因素识别MHD患者早期再入院高危人群并采取干预措施,以提高其医疗质量,降低医疗成本,优化医疗资源。

本文引用格式

梁琪 , 王志虎 , 王冰洁 , 刘洋 , 张春梅 . 维持性血液透析患者早期再入院影响因素的Meta分析[J]. 中国血液净化, 2024 , 23(03) : 223 -226,231 . DOI: 10.3969/j.issn.1671-4091.2024.03.015

Abstract

Objective  To systematically evaluate the risk factors for early readmission of maintenance hemodialysis (MHD) patients, and to provide a reference for early identification and intervention.  Methods  A systematic search for risk factors for early readmission in MHD patients in the databases of PubMed, Embase, Web of Science, Cochrane Library, CNKI, WanFang, VIP and CBM from establishment of the databases to February 2023 was carried out. Meta-analysis was performed by Revman5.3 software.  Results  A total of 13 articles with 774,826 patients were included. Meta-analysis results showed that female (OR=1.08, 95% CI: 1.05~1.11, P<0.001), smoking (OR=1.56, 95% CI: 1.09~2.23, P=0.010), alcohol consumption (OR=1.24, 95% CI: 1.04~1.48, P=0.020), medication misuse (OR=1.08, 95% CI: 1.05~1.11, P<0.001), cerebrovascular disease (OR=1.17, 95% CI: 1.08~1.26, P<0.001), coronary artery disease (OR=1.27, 95% CI: 1.08~1.49,<0.001), heart failure (OR=1.28, 95% CI: 1.19~1.37, P<0.001), diabetes (OR=1.13, 95% CI: 1.06~1.20, P<0.001), chronic obstructive pulmonary disease (OR=1.20, 95% CI: 1.12~1.28, P<0.001), Hb (MD=-9.29, 95% CI: -14.06~-4.53, P<0.001), Alb (MD=-3.51, 95% CI: -4.44~-2.58, P<0.001) and central venous catheterization (OR=1.25, 95% CI: 1.15~1.37, P<0.001) were the risk factors for early readmission in MHD patients.   Conclusion  Clinical staff can identify the MHD patients with the risk of early readmission based on the above factors and take interventions to improve their quality of care, reduce healthcare costs and optimize healthcare resources.

参考文献

[1] Wang M, Rao H, Zhang Y. Effect of predictive nursing on the comfort, illness perception, metabolism of calcium and phosphorus, and complications in hemodialysis patients[J]. Am J Transl Res, 2021,13(5):4978-4986.
[2] Plantinga L C, Masud T, Lea J P, et al. Post-hospitalization dialysis facility processes of care and hospital readmissions among hemodialysis patients: a retrospective cohort study[J]. BMC Nephrol, 2018,19(1):186.
[3] Mathew A T, Strippoli G, Ruospo M, et al. Reducing hospital readmissions in patients with end-stage kidney disease[J]. Kidney Int, 2015,88(6):1250-1260.
[4] Plantinga L C, King L, Patzer R E, et al. Early hospital readmission among hemodialysis patients in the United States is associated with subsequent mortality[J]. Kidney Int, 2017,92(4):934-941.
[5] Ross K H, Jaar B G, Lea J P, et al. Long-term outcomes among Medicare patients readmitted in the first year of hemodialysis: a retrospective cohort study[J]. BMC Nephrol, 2019,20(1):285.
[6] Adisa O, Jaar B G, Masud T, et al. Association of social worker-assessed psychosocial factors with 30-day hospital readmissions among hemodialysis patients[J]. BMC Nephrol, 2018,19(1):360.
[7] Mathew A T, Rosen L, Pekmezaris R, et al. Potentially Avoidable Readmissions in?United States Hemodialysis Patients[J]. Kidney Int Rep, 2018,3(2):343-355.
[8] Flythe J E, Hilbert J, Kshirsagar A V, et al. Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study[J]. Am J Nephrol, 2017,45(5):400-408.
[9] Chan L, Chauhan K, Poojary P, et al. National Estimates of 30-Day Unplanned Readmissions of Patients on Maintenance Hemodialysis[J]. Clin J Am Soc Nephrol, 2017,12(10):1652-1662.
[10] Lin E, Bhattacharya J, Chertow G M. Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis[J]. J Am Soc Nephrol, 2019,30(2):323-335.
[11] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010,25(9):603-605.
[12] 陈璐, 陈中腾, 徐丽云, 等. 维持性血液透析患者31d内非计划再入院的风险评估[J]. 中国中西医结合肾病杂志, 2020,21(05):408-410.
[13] 董巧荣, 胡桂才, 邢玮, 等. 血清白蛋白浓度影响维持性血液透析患者再住院的发生[J]. 现代预防医学, 2011,38(23):5006-5007.
[14] 黄云霞, 陈雪亮, 朱晓峰, 等. 维持性血液透析患者再入院相关因素分析[J]. 中华全科医学, 2017,15(12):2179-2181.
[15] 孔德玮, 涂晓文. 维持性血液透析患者30天内再入院危险因素分析[J]. 北京医学, 2016,38(08):833-836.
[16] 牛建英, 袁瑾, 罗丽红, 等. 血红蛋白浓度对维持性血液透析患者再入院的影响[J]. 中国中西医结合肾病杂志, 2006,07(09):522-523.
[17] 宋琼, 吴蓉, 李建华. 维持性血液透析患者再入院临床风险因素的分析[J]. 河北医科大学学报, 2018,39(02):137-141.
[18] 王喆, 魏芳, 王立华, 等. 低蛋白血症和贫血对维持性血液透析患者再入院的影响[J]. 临床荟萃, 2009,24(14):1231-1233.
[19] 徐文峰, 范元硕, 蔡虎志, 等. 71例维持性血液透析患者再入院原因分析[J]. 中国血液净化, 2017,16(07):455-458.
[20] Golestaneh L, Bellin E, Southern W, et al. Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study[J]. BMC Nephrol, 2017,18(01):352.
[21] Hickson L J, Thorsteinsdottir B, Ramar P, et al. Hospital readmission among new dialysis patients associated with young age and poor functional status[J]. Nephron, 2018,139(1):1-12.
[22] Erickson K F, Winkelmayer W C, Chertow G M, et al. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis[J]. J Am Soc Nephrol, 2014,25(9):2079-2087.
[23] Flythe J E, Katsanos S L, Hu Y, et al. Predictors of 30-Day Hospital Readmission among Maintenance Hemodialysis Patients: A Hospital's Perspective[J]. Clin J Am Soc Nephrol, 2016,11(6):1005-1014.
[24] Siracuse J J, Shah N K, Peacock M R, et al. Thirty-day and 90-day hospital readmission after outpatient upper extremity hemodialysis access creation[J]. J Vasc Surg, 2017,65(5):1376-1382.
[25] King C, Mulugeta A, Nabi F, et al. Mendelian randomization case-control PheWAS in UK Biobank shows evidence of causality for smoking intensity in 28 distinct clinical conditions[J]. EClinicalMedicine, 2020,26:100488.
[26] Li Y, Zhu B, Song N, et al. Alcohol consumption and its association with chronic kidney disease: Evidence from a 12-year China health and Nutrition Survey[J]. Nutr Metab Cardiovasc Dis, 2022,32(6):1392-1401.
[27] Manley H J, Aweh G, Weiner D E, et al. Multidisciplinary Medication Therapy Management and Hospital Readmission in Patients Undergoing Maintenance Dialysis: A Retrospective Cohort Study[J]. Am J Kidney Dis, 2020,76(1):13-21.
[28] Wetmore J B, Molony J T, Liu J, et al. Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study[J]. J Am Heart Assoc, 2018,7(4):e7231.
[29] Chen R, Yang C, Zhu M, et al. Association of cardiovascular disease with 30-day hospital readmission in Chinese patients receiving maintenance dialysis[J]. Ann Transl Med, 2021,9(8):617.
[30] Plantinga L C, King L M, Masud T, et al. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study[J]. Nephrol Dial Transplant, 2018,33(7):1215-1223.
[31] 石彬, 王海芳, 汪小华, 等. 维持性血液透析病人容量管理行为水平及其对再住院率的影响[J]. 护理研究, 2018,32(14):2221-2227.
[32] Chen Y J, Rhee C, Senturk D, et al. Association of US Dialysis Facility Staffing with Profiling of Hospital-Wide 30-Day Unplanned Readmission[J]. Kidney Dis (Basel), 2019,5(3):153-162.
[33] Wjayantii S, Yetti K, Masfuri. Analysis of the factors affecting the hospital readmission incidence of hemodialysis patients in Bandar Lampung, Indonesia[J]. Enfermería Clínica, 2019,29:720-724.
[34] Lacson E J, Wang W, Hakim R M, et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access[J]. Am J Kidney Dis, 2009,53(1):79-90.
[35] Coscas R, Petrica N, Massy Z, et al. Readmissions Following Arteriovenous Access Creation for Haemodialysis in a French National Database[J]. Eur J Vasc Endovasc Surg, 2022,64(6):703-710.
文章导航

/

[an error occurred while processing this directive]